SGLT2 inhibition in the management of type 2 diabetes: Potential impact on CVD Risk
Teaching slides prepared and presented by Prof. Silvio E Inzucchi, New Haven, CT, USA at EBAC accredited symposium 'Managing Diabetes & CVD: Exploring new evidence and opportunities' at ESC 2015 in London.
Download presentation in PDFLecture 3 prof Inzucchi SGLT2 inhibition in the management of type 2 diabetes.pdf (2,5MB)
Click on images to view presentation
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: